Soulmates Ventures
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Antiverse secures £7m Series A led by Soulmates Ventures for AI-designed antibodies targeting undruggable diseases
Antiverse develops therapeutic antibodies designed using machine learning and built in its own laboratories. It generates and tests antibody candidates against difficult disease targets, including membrane proteins, for pharmaceutical and foundation partners.
Rightcharge secures £1.6m seed round led by Soulmates Ventures to simplify EV charging data for Europe's fleets
Rightcharge provides a payments platform for electric vehicle fleets that automates home charging reimbursements and consolidates public charging costs, linking directly to energy accounts to reduce admin, errors and charging expenses for businesses.
Signapse closes £2m seed round to accelerate accessibility for deaf people
Signapse builds generative AI software that translates written and spoken English into sign language, improving accessibility by enabling scalable, video-based communication for Deaf users across digital and physical environments.
More venture news
- 3 Mar 2026
Antiverse secures £7m Series A led by Soulmates Ventures for AI-designed antibodies targeting undruggable diseases
Series ALife Sciences - 25 Feb 2026
SolveAI raises £37m Series A led by GV to let employees build enterprise software with conversational AI
Series ADeveloper Tools - 19 Feb 2026
Stacks announces a £17m Series A led by Lightspeed to reinvent finance ops with its all-in-one accounting workspace
Series AFintech
